Skip Navigation LinksHome > August 2010 - Volume 32 - Issue 6 > Newborn Screening for Hermansky-Pudlak Syndrome Type 3 in Pu...
Journal of Pediatric Hematology/Oncology:
doi: 10.1097/MPH.0b013e3181e5e1f1
Original Articles

Newborn Screening for Hermansky-Pudlak Syndrome Type 3 in Puerto Rico

Torres-Serrant, Maribel MD*; Ramirez, Sonia I. MT*; Cadilla, Carmen L. PhD; Ramos-Valencia, Gilberto PhD; Santiago-Borrero, Pedro J. MD*

Collapse Box


Background: Hermansky-Pudlak syndrome (HPS) is an autosomal recessive disorder characterized by albinism, mucocutaneous bleeding, and storage of ceroid material in macrophages. Patients who are not easily identified by physical characteristics (mostly HPS-3 patients) may have hemorrhagic complications with trauma or surgery.

Objective: To determine the prevalence of HPS-3 in Puerto Rican newborns using DNA pooling technique.

Design/Methods: Twelve percent of annual Puerto Rican births were tested randomly by polymerase chain reaction for the HPS-3 mutation, using pooled DNA extracted from dried blood samples.

Results: HPS-3 mutation was detected in 75 samples. Two newborns were found to be homozygous. Carrier frequency was 1:85 (1.18%).

Conclusions: The HPS-3 carrier frequency found (1.18%) justifies universal newborn screening in Puerto Rico. DNA pooling reduces time and labor in newborn screening thus facilitating early diagnosis and treatment of children with HPS-3 and the provision of genetic counseling to parents and relatives.

© 2010 Lippincott Williams & Wilkins, Inc.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.

Connect With Us


For additional oncology content, visit LWW Oncology Journals on Facebook.